U.S., Feb. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07403760) titled 'Wellbeing and Survival Improvement With Event Reduction by Ablation for Atrial Fibrillation in the Very Elderly' on Feb. 04.
Brief Summary: The WISER-AF trial is a multicenter, double-blind, sham-controlled, randomized controlled trial. It aims to evaluate the efficacy and safety of catheter ablation compared to a sham procedure in improving the quality of life (SF-36 score) in very elderly patients (aged >=80 years) with symptomatic atrial fibrillation over a 6-month follow-up period.
Study Start Date: Jan. 30
Study Type: INTERVENTIONAL
Condition:
Atrial Fibrillation (AF)
Intervention:
PROCEDURE: Catheter Ablation
Patients u...